Botulinum Toxin Injections
J15
39 active Medicare policies list N30.11, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5
J5 · Effective Feb 22, 2026
4 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of N30.11 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2024 | Covered |
| Broth Culture Testing for Interstitial Cystitis | Sep 15, 2023 | Covered |
| Chronic Pelvic Pain, Endometriosis, and Other Indications: Selected Treatments | Oct 5, 2023 | Covered |
| Prolotherapy and Sclerotherapy | Apr 11, 2023 | Covered |
J5
J8 · Effective Feb 22, 2026
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Nov 5, 2023
JM · Effective Nov 5, 2023
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Oct 1, 2026
J5 · Effective Mar 5, 2026
National · Effective Oct 1, 2025
National · Effective Jun 17, 2025
National · Effective Apr 6, 2026
National · Effective Mar 5, 2026
National · Effective Oct 2, 2025
J6 · Effective Apr 1, 2026